Pirlindole mesylate,
60762-57-4,
8-methyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino[3,2,1-jk]carbazole methanesulfonate,
207572-66-5,
MLS002222320,
8-Methyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino-[3,2,1-jk]carbazole methanesulfonate,
SMR001307263,
DSSTox_CID_25660,
DSSTox_RID_81037,
DSSTox_GSID_45660,
CAS-207572-66-5,
SR-01000597871,
NCGC00024749-01,
AC1MD1J6,
ARONIS24188,
methanesulfonic acid; pirlindole,
SCHEMBL3761340,
CHEMBL1713992,
DTXSID6045660,
cid_2829432,
CTK8E5596,
BBC/335,
BDBM114580,
HMS1571C07,
HMS2098C07,
HMS2233I05,
HMS3266N03,
HMS3373G12,
HMS3675D09,
HMS3715C07,
ZX-AS004547,
Tox21_110923,
BN0422,
SBB080677,
AKOS003242074,
Tox21_110923_1,
CCG-220973,
KS-000048I6,
NCGC00024749-04,
TR-020946,
Z-0850,
SR-01000597871-1,
SR-01000597871-4,
I14-27175,
2,3,3a,4,5,6-Hexahydro-8-methyl-1H-pyrazino[3,2,1-j,k]carbazolemesylate,
2,3,3a,4,5,6-Hexahydro-8-methyl-1H-pyrazino[3,2,1-j,k]carbazole mesylate,
pirlindol,
Pirlindole,
Pirlindolum,
Pirlindole [INN],
Pirlindolum [INN-Latin],
UNII-V39YPH45FZ,
Pirlindol [INN-Spanish, French],
C15-H18-N2,
CID2829432,
NCGC00017123-01,
1H-Pyrazino[3,2,1-jk]carbazole, 2,3,3a,4,5,6-hexahydro-8-methyl-,